Skip to content

Early Ambulation to Reduce Hospital Length of Stay

Early Ambulation to Reduce Hospital Length of Stay

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04444453
Acronym
EARLY
Enrollment
38
Registered
2020-06-23
Start date
2020-10-21
Completion date
2022-09-01
Last updated
2023-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulation, Wearable Devices

Keywords

length of stay, hospitalization

Brief summary

Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device (pedometer) measuring steps and ambulation sessions decreases hospital LOS (primary outcome), decreases hospital LOS index (LOSI), decreases time to first ambulation, decreases time to first bowel movement (BM), decreases incidence of VTEs, and decreases costs (secondary outcomes). In a pilot randomized control trial, we will randomize 150 total adult patients admitted to UF Health Jacksonville in a 1:1 fashion to usual care and wearable pedometer or usual care. Patients randomized to the study intervention will receive a wearable pedometer upon admission, to be worn for the duration of their inpatient stay. Study outcome measures to be compared between the pedometer and no pedometer group include hospital LOS (primary outcome), hospital LOSI, time to first ambulation, time to first BM, incidence of VTEs, patient experience, and costs (secondary outcomes).

Interventions

DEVICEWearable Pedometer

Pedometer worn on wrist

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Patients ages \> or equal to 18 years 2. Patient has capacity to undergo informed consent 3. Admitted to UF Health Jacksonville 8N progressive inpatient unit 4. Inpatient physician orders for patient ambulation and/or activity as tolerated upon hospital admission 5. Patient with a Fall Predictive Analytics score category of low risk 6. Patient with a Morse Fall Scale (MFS) of \< or equal to 50 7. No contraindications to wearing a wrist pedometer (no skin breakdown, overlying skin infections, contact dermatitis, or indwelling catheters/need for venipuncture at wrist site)

Exclusion criteria

1. Patient \< 18 years of age 2. Patient without capacity to undergo informed consent 3. Patient with a 'do not ambulate' order or has order for bed rest or other contraindication to ambulation (i.e., fall risk) or dependent on more than minimal assistance to ambulate 4. Patient with a Fall Predictive Analytics score category of high risk 5. Patient with MFS \> 50 or labelled by clinical team as fall risk 6. Non-English speaking 7. In law enforcement custody or ward of the state 8. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Hospital Length of StayUp to 1 monthTime patient is admitted in hospital

Secondary

MeasureTime frame
Hospital length-of-stay indexUp to 1 month
Time to first ambulationUp to 1 month
Time to first bowel movementUp to 1 month
Rate of venous thromboembolismUp to 1 month
Total hospitalization costsUp to 1 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026